Reversible fetal renal failure after maternal treatment with Candesartan: A case report

Reproductive Toxicology

Volumn 29, Issue 3, 2010, Pages 381-382

  Munk, Peter Scott ^a,b   von Brandis, Philip ^a   Larsen, Alf Inge ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Angiotensin receptor blockers; Fetal kidney failure; Oligohydramnios; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ATOSIBAN; BETAMETHASONE; CANDESARTAN; CREATININE; METOPROLOL; RAMIPRIL;

ADULT; AMNION FLUID; ARTICLE; CASE REPORT; CREATININE CLEARANCE; DELIVERY; DIURESIS; ECHOGRAPHY; FEMALE; FETUS; FETUS BLADDER; FETUS DISEASE; GESTATION PERIOD; HEART FAILURE; HUMAN; KIDNEY FAILURE; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREGNANCY; PREMATURE LABOR; PROGNOSIS; SYSTOLIC HEART MURMUR; URINALYSIS;

ADULT; AMNIOTIC FLUID; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CREATININE; FEMALE; FETUS; HUMANS; HYPERTENSION; INFANT, NEWBORN; KIDNEY; KIDNEY FAILURE; PREGNANCY; TETRAZOLES;

EID: 77951621931     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.01.010     Document Type: Article

References (9)

1. Bowen M.E., Ray W.A., Arbogast P.G., Ding H., Cooper W.O. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol 2008, 198(291):e291-295.
2. Pearson G.D., Veille J.C., Rahimtoola S., Hsia J., Oakley C.M., Hosenpud J.D., et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA 2000, 283:1183-1188.
3. Kato K., Okuda M., Ishikawa H., Takahashi T., Hirahara F. Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin ii receptor antagonist was suspected. J Obstet Gynaecol Res 2008, 34:242-246.
4. Miura K., Sekine T., Iida A., Takahashi K., Igarashi T. Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker. Pediatr Nephrol 2009, 24:1235-1238.
5. Serreau R., Luton D., Macher M.A., Delezoide A.L., Garel C., Jacqz-Aigrain E. Developmental toxicity of the angiotensin ii type 1 receptor antagonists during human pregnancy: a report of 10 cases. Bjog 2005, 112:710-712.
6. Gersak K., Cvijic M., Cerar L.K. Angiotensin ii receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 2009, 28:109-112.
7. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.
8. Sekine T., Miura K., Takahashi K., Igarashi T. Children's toxicology from bench to bed-drug-induced renal injury (1): the toxic effects of arb/acei on fetal kidney development. J Toxicol Sci 2009, 34(Suppl. 2):SP245-SP250.
9. Boubred F., Vendemmia M., Garcia-Meric P., Buffat C., Millet V., Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006, 29:397-419.